Dr ZHU Tian Participated in Panel Discussion on Healthtech Innovations at Hong Kong Pavilion during 2024

LEAP 2024 in Riyadh, Saudi Arabia

We are thrilled to share that our Co-Founder and CEO, Dr. ZHU Tian, recently joined a landmark delegation led by the Innovation, Technology and Industry Bureau of the Hong Kong SAR Government to the Middle East. Dr. ZHU also participated in a panel discussion on “Hong Kong Healthtech Innovations Drive G Transformation for Generations to Come” at the Hong Kong Pavilion LEAP 2024 in Riyadh, Saudi Arabia on 4 March 2024.

During the panel discussion, Dr. ZHU, along with Mr. Albert WONG, CEO of HKSTP, and other esteemed guests, had the opportunity to discuss the potential for R&D collaboration investment for startups between Hong Kong and the Middle East.

Co-Founder and CEO of GenEditBio, Tian ZHU, PhD (second from right), joined a landmark delegation led by the Secretary for Innovation, Technology and Industry, Prof. Dong SUN (first from left), to the Middle East in March 2024. (Photo: HKSTP)

(Second from left) Co-Founder and CEO of GenEditBio, Tian ZHU, PhD, participated in a panel discussion at LEAP 2024 on 4 March. (Photo: HKSTP)

At GenEditBio, we are excited about the boundless collaboration opportunities in the field of genomics and CRISPR-based genome-editing therapeutics, aligning with the vision set forth by Saudi Vision 2030. Our aim is to enhance the health and well-being of individuals globally, benefiting patients worldwide.

About LEAP
LEAP is an annual flagship innovation and technology event organized by the government of the Kingdom of Saudi Arabia. With over 172,000 attendees and 1800+ global tech exhibitors, LEAP provides a platform for showcasing groundbreaking ideas and building partnerships. To learn more about this event, visit https://onegiantleap.com.

#GENEDITBIO #HKSTP #LEAP2024 #CRISPR